43 filings
POS EX
CHRO
Chromocell Therapeutics Corp.
16 Apr 24
Additional exhibits for listing
6:09pm
424B3
CHRO
Chromocell Therapeutics Corp.
16 Apr 24
Prospectus supplement
5:49pm
424B3
CHRO
Chromocell Therapeutics Corp.
16 Apr 24
Prospectus supplement
5:45pm
10-K
2023 FY
CHRO
Chromocell Therapeutics Corp.
16 Apr 24
Annual report
4:48pm
S-8
CHRO
Chromocell Therapeutics Corp.
12 Apr 24
Registration of securities for employees
7:22pm
8-K
x5wckiv wx
9 Apr 24
Chromocell Issues Letter to Stockholders from Chief Executive Officer
8:30am
NT 10-K
b2vf vy1j
1 Apr 24
Notice of late annual filing
9:00am
8-K
jldtqpqpjsesgsnlp6r7
21 Mar 24
Chromocell Announces Formal Launch of Eye Pain Treatment Program and Hiring of Dr. Simon Chandler
9:00am
8-K
wwp9h9oqt
18 Mar 24
Chromocell Names Frank Knuettel as Chief Executive Officer, Removing Interim Status Held Since July 2023
4:05pm
8-K
b9bs 36mskmr
13 Mar 24
Regulation FD Disclosure
8:00am
8-K
izx6pv bb7jpun
22 Feb 24
Chromocell Therapeutics Announces Pricing of Upsized $6.6 Initial Public Offering
4:05pm
424B4
l5duo
20 Feb 24
Prospectus supplement with pricing info
5:30pm
424B4
dj8b39 1uf
20 Feb 24
Prospectus supplement with pricing info
5:28pm
SEC STAFF
n93sf v7xki
20 Feb 24
SEC staff action: Order
12:00am
POS EX
eqp 1pysnb6avbe
15 Feb 24
Additional exhibits for listing
9:56pm
CERT
r47iuk2yokrye 4m
15 Feb 24
Certification of approval for exchange listing
11:46am
8-A12B
os1onme
15 Feb 24
Registration of securities on exchange
11:35am
EFFECT
9dck0pn76ig 1km2
15 Feb 24
Notice of effectiveness
12:15am
FWP
wvmx2
12 Feb 24
Free writing prospectus
8:09am